CDEK
← All drugs Report issue

gls-010

mAbexperimental

Clinical trial activity

8 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
7
Phase 3
2
Phase 4
0

Earliest trial started Jul 1, 2017 (NCT03713905)

Timeline

2010s

  1. Jan 1, 2017

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2022

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05978401Phase 1/Phase 2 (Phase 2)Aug 10, 2023Guangzhou Gloria Biosciences Co., Ltd.
NCT05900765Phase 2Jun 14, 2023Guangzhou Gloria Biosciences Co., Ltd., Sun Yat-Sen University
NCT05798819Phase 3May 1, 2023Guangzhou Gloria Biosciences Co., Ltd.
NCT05909436Phase 1/Phase 2 (Phase 2)Oct 31, 2022Guangzhou Gloria Biosciences Co., Ltd.
NCT05518318Phase 3Sep 30, 2022Guangzhou Gloria Biosciences Co., Ltd.
NCT03972722Phase 2May 15, 2019Fudan University, Guangzhou Gloria Biosciences Co., Ltd.
NCT03655483Phase 2Aug 24, 2018Guangzhou Gloria Biosciences Co., Ltd., Peking University
NCT03713905Phase 1Jul 1, 2017Guangzhou Gloria Biosciences Co., Ltd., Peking University
Showing 8 of 8 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Guangzhou Gloria Biosciences Co., Ltd.For profit8732017
Peking UniversityAcademic/Hospital2022017
Fudan UniversityAcademic/Hospital1012019
Sun Yat-Sen UniversityAcademic/Hospital1112023
4 organizations
Page 1 / 1